Conventional and conventional plus modified ultrafiltration during cardiac surgery in high-risk congenital heart

M A Maluf1, C Mangia, C Silva

  • 1Division of Cardiovascular Surgery, Universidade Federal de São Paulo, Rua Apeninos, 930 Conj 182, Paraiso, CEP 045104-020, São Paulo, Brazil. miguel@bes-way.com.br

Insights

Conventional ultrafiltration (CUF) and modified ultrafiltration (MUF) are safe for pediatric cardiac surgery. Both techniques effectively stabilize patients, with MUF showing greater fluid removal but no significant differences in clinical outcomes.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Critical Care Medicine

Background:

  • Cardiopulmonary bypass (CPB) in pediatric cardiac surgery can lead to fluid overload and inflammation.
  • Conventional ultrafiltration (CUF) during CPB helps reduce excess body water.
  • Modified ultrafiltration (MUF) after CPB may remove inflammatory mediators and improve hemodynamics.

Purpose of the Study:

  • To critically assess the efficiency of CUF and MUF techniques in pediatric congenital heart disease surgeries.
  • To compare the clinical outcomes of CUF versus CUF combined with MUF (CUF+MUF) in young patients undergoing CPB.

Main Methods:

  • A prospective nonrandomized study involving 41 patients (9-36 months) undergoing cardiac defect correction with CPB.
  • Patients were divided into two groups: CUF (ultrafiltration during CPB) and CUF+MUF (ultrafiltration during and after CPB).
  • Outcomes compared included ventilator support, pediatric intensive care unit (PICU) stay, hospital stay, and transfusion requirements.

Main Results:

  • The CUF+MUF group demonstrated significantly greater ultrafiltrate volume compared to the CUF group.
  • No statistically significant differences were found between the groups in terms of ventilatory support, PICU stay, or hospital stay.
  • Transfusion requirements, hematocrit, and platelet counts did not differ significantly between the CUF and CUF+MUF groups.

Conclusions:

  • Both CUF and CUF+MUF are safe and effective methods for patient stabilization in congenital heart disease surgery.
  • The choice of technique appears independent of surgical diagnosis or complexity.
  • Further research with larger patient populations is recommended to explore various clinical variables.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...